Abstract:The quorum sensing (QS) circuit plays a role in the precise regulation of genes controlling virulence factors and biofilm formation in Pseudomonas aeruginosa. QS-controlled biofilm formation by Pseudomonas aeruginosa in clinical settings has remained controversial due to emerging drug resistance; therefore, screening diverse compounds for anti-biofilm or anti-QS activities is important. This study demonstrates the ability of sub-minimum inhibitory concentrations (sub-MICs) of baicalin, an active natural compound extracted from the traditional Chinese medicinal Scutellaria baicalensis, to inhibit the formation of Pseudomonas aeruginosa biofilms and enhance the bactericidal effects of various conventional antibiotics in vitro. In addition, baicalin exerted dose-dependent inhibitory effects on virulence phenotypes (LasA protease, LasB elastase, pyocyanin, rhamnolipid, motilities and exotoxin A) regulated by QS in Pseudomonas aeruginosa. Moreover, the expression levels of QS-regulatory genes, including lasI, lasR, rhlI, rhlR, pqsR and pqsA, were repressed after sub-MIC baicalin treatment, resulting in significant decreases in the QS signaling molecules 3-oxo-C12-HSL and C4-HSL, confirming the ability of baicalin-mediated QS inhibition to alter gene and protein expression. In vivo experiments indicated that baicalin treatment reduces Pseudomonas aeruginosa pathogenicity in Caenorhabditis elegans. Greater worm survival in the baicalin-treated group manifested as an increase in the LT50 from 24 to 96 h. In a mouse peritoneal implant infection model, baicalin treatment enhanced the clearance of Pseudomonas aeruginosa from the implants of mice infected with Pseudomonas aeruginosa compared with the control group. Moreover, the combination of baicalin and antibiotics significantly reduced the numbers of colony-forming units in the implants to a significantly greater degree than antibiotic treatment alone. Pathological and histological analyses revealed mitigation of the inflammatory response and reduced cell infiltration in the peritoneal tissue surrounding the implants after baicalin treatment. Measurement of the cytokine levels in the peritoneal lavage fluid of mice in the baicalin treatment group revealed a decrease in IL-4, an increase in interferon γ (IFN-γ), and a reversed IFN-γ/IL-4 ratio compared with the control group, indicating that baicalin treatment activated the Th1-induced immune response to expedite bacterial load clearance. Based on these results, baicalin might be a potent QS inhibitor and anti-biofilm agent for combating Pseudomonas aeruginosa biofilm-related infections.

Baicalin ameliorates multidrug-resistant Pseudomonas aeruginosa induced pulmonary inflammation in rat via arginine biosynthesis

Baicalin inhibits APEC-induced lung injury by regulating gut microbiota and SCFA production

Baicalin Liposome Alleviates Lipopolysaccharide-Induced Acute Lung Injury in Mice via Inhibiting TLR4/JNK/ERK/NF- κ B Pathway

Baicalin Inhibits Biofilm Formation, Attenuates the Quorum Sensing-Controlled Virulence and Enhances Pseudomonas Aeruginosa Clearance in a Mouse Peritoneal Implant Infection Model

Baicalin Liposome Alleviates Lipopolysaccharide-Induced Acute Lung Injury in Mice Via Inhibiting TLR4/JNK/ERK/NF-κB Pathway

Baicalin Improves Survival in A Murine Model of Polymicrobial Sepsis Via Suppressing Inflammatory Response and Lymphocyte Apoptosis

Baicalin Relieves LPS-Induced Lung Inflammation via the NF-κB and MAPK Pathways

Effect of Baicalin on Inflammatory Mediator Levels and Microcirculation Disturbance in Rats with Severe Acute Pancreatitis

Baicalin Ameliorates Mycoplasma Gallisepticum-Induced Inflammatory Injury in the Chicken Lung Through Regulating the Intestinal Microbiota and Phenylalanine Metabolism.

Baicalin relieves Mycoplasma pneumoniae infection‐induced lung injury through regulating microRNA‐221 to inhibit the TLR4/NF‐κB signaling pathway

Baicalin Inhibits Inflammation in Rats with Chronic Obstructive Pulmonary Disease by the TLR2/MYD88/NF-κBp65 Signaling Pathway

Protective effect of baicalin on the regulation of Treg/Th17 balance, gut microbiota and short-chain fatty acids in rats with ulcerative colitis

Baicalin Represses Type Three Secretion System of Pseudomonas aeruginosa through PQS System

Protective effect of baicalin against lipopolysaccharideinduced acute lung injury in rats, and the mechanism of action

Baicalin inhibits inflammation of lipopolysaccharide-induced acute lung injury <i>via</i> toll like receptor-4/myeloid differentiation primary response 88/nuclear factor-kappa B signaling pathway

Baicalin Represses Type Three Secretion System of <i>Pseudomonas aeruginosa</i> through PQS System

Effects of Baicalin on Pulmonary Functions of Acute Respiratory Distress Syndrome Induced by Oleic Acid in Rats

Baicalin Weakens Staphylococcus Aureus Pathogenicity by Targeting Sortase B

Baicalin Circumvents Anti-Pd-1 Resistance by Regulating the Gut Microbiota Metabolite Short-Chain Fatty Acids

Baicalein ameliorates SEB-induced acute respiratory distress syndrome in a microbiota-dependent manner

Baicalin alleviates bleomycin-induced early pulmonary fibrosis in mice via the mitoKATP signaling pathway